Centralized data science platform streamlines clinical study data management for swift, insight-driven clinical decisions and therapeutic advancements

- Seamless integration with Spotfire^® for powerful visual analytics enabling flexibility, easy customization and scalability

- Fosters cross-functional collaboration and improves overall efficiency in clinical research and development

Revvity, Inc. has announced the launch of Signals ClinicalTM, a cutting-edge software-as-a-service (SaaS) solution by its software and informatics division, Revvity Signals. This platform aims to revolutionize clinical trial data management by centralizing all study data, facilitating swift, insight-driven decisions for accelerated therapeutic advancements. Integrated with Spotfire® for robust visual analytics, Signals Clinical enhances flexibility, customization, and scalability, fostering cross-functional collaboration and improving overall efficiency in clinical research and development.

Kevin Willoe, Senior Vice President, and General Manager of Revvity Signals Software, Inc., underscored the transformative impact of Signals Clinical, stating, "In the pharmaceutical, biotechnology, and contract research industries, expediting the delivery of new treatments is crucial. Signals Clinical addresses this need by providing a solution that prioritizes patient safety while enabling data-driven decision-making with near real-time analytics. By combining this platform with advanced data visualization tools, we empower our clients to navigate clinical development complexities efficiently, accelerating the delivery of new therapies to patients."